查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1239513

组织扩张器市场:按病变部位(下肢,上肢,其他),产品形状(矩形,新月形,圆形,其他),最终用户(医院,美容诊所,其他),全球机会分析和行业预测,2021 年2031-2031

Tissue Expanders Market By Lesion Site (Lower Extremity, Upper Extremity, Others), By Product Shape (Rectangular, Crescent, Round, Others), By End User (Hospitals, Cosmetic Clinics, Others): Global Opportunity Analysis & Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 397 Pages | 商品交期: 2-3个工作天内

价格

2021 年全球组织扩张器市场规模为 6.715 亿美元，2022 年至 2031 年的复合年增长率为 5.8%，预计到 2031 年将达到 11.8 亿美元。

组织扩张器是由硅胶和填充物成分製成的球囊，预成型为预成型的假体，在扩张器的表面内置有阀门系统（早期的扩张器具有这种结构，但今天），或者通过一个通过柔性硅橡胶填充管连接到膨胀器的远程阀（现在几乎所有的膨胀器都有一个远程阀）。 远程阀门和填充管的主要优点是它们使注射部位远离球囊，从而消除了扩张器充气过程中球囊被刺穿的风险。 此外，远程定位允许将其放置在容易感觉到的皮肤下。

组织扩张器市场的增长受到各种组织扩张器开发技术进步和乳腺癌患病率上升的推动。 此外，市场主要参与者的产品发布和产品批准等各种策略的增加预计将推动市场增长。 由于乳腺癌是女性最常见的癌症类型，需要进行乳房切除术以去除恶性细胞，因此预计将增加使用四肢组织扩张器进行乳房重建。 因此，预计越来越多的女性乳腺癌患者将推动对组织扩张器的需求并推动市场增长。

越来越多地采用微创手术来改善美学外观，预计将推动对组织扩张器的需求并促进市场增长。 例如，国际美容整形外科学会报告称，2020 年，全球整形外科医生进行了约 10,129,528 例整容手术。 组织扩张器用于头皮重建、乳房重建、口腔颌面重建和烧伤疤痕修復。 因此，烧伤和口腔颌面部畸形的增加导致对组织扩张器的需求激增。

内容

第一章介绍

第 2 章执行摘要

第 3 章市场概述

  • 市场定义和范围
  • 主要发现
    • 主要影响因素
    • 主要投资机会
  • 波特的五力分析
    • 供应商的议价能力
    • 买家的议价能力
    • 替代品的威胁很大
    • 新进入者的威胁很大
    • 竞争激烈
  • 市场动态
    • 司机
      • 增加微创手术
      • 乳腺癌患病率上升
      • 对整容手术的认识不断提高
    • 约束因素
      • 重建手术的副作用
    • 机会
      • 关键策略采用率的增加：按市场参与者
  • 分析 COVID-19 对市场的影响

第 4 章组织扩张器市场：按病变部位分类

  • 概览
    • 市场规模和预测
  • 下肢
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 上边缘
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 其他
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
    • 其他组织扩张器市场，按应用分类
      • 乳房再造市场规模和预测：按地区
      • 面部再造市场规模和预测：按地区
      • 其他市场规模和预测：按地区

第 5 章组织扩张器市场：按产品形式分类

  • 概览
    • 市场规模和预测
  • 矩形
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 新月
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 圆形
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 其他
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类

第 6 章组织扩张器市场：按最终用户分类

  • 概览
    • 市场规模和预测
  • 医院
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 美容诊所
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 其他
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类

第 7 章组织扩张器市场：按地区

  • 概览
    • 市场规模和预测：按地区
  • 北美
    • 主要趋势和机会
    • 市场规模和预测：按部分分类
      • 北美和其他组织扩张剂市场：按应用分类
    • 市场规模和预测：按产品形状分类
    • 最终用户的市场规模和预测
    • 市场规模和预测：按国家/地区分类
      • 美国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
      • 加拿大
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
      • 墨西哥
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
  • 欧洲
    • 主要趋势和机会
    • 市场规模和预测：按部分分类
      • 欧洲其他组织扩张剂市场：按应用分类
    • 市场规模和预测：按产品形状分类
    • 最终用户的市场规模和预测
    • 市场规模和预测：按国家/地区分类
      • 德国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
      • 法国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
      • 英国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
      • 意大利
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
      • 西班牙
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
      • 其他欧洲
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
  • 亚太地区
    • 主要趋势和机会
    • 市场规模和预测：按部分分类
      • 亚太地区其他组织扩张剂市场，按应用分类
    • 市场规模和预测：按产品形状分类
    • 最终用户的市场规模和预测
    • 市场规模和预测：按国家/地区分类
      • 日本
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
      • 中国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
      • 印度
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
      • 澳大利亚
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
      • 韩国
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
      • 其他亚太地区
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
  • 拉丁美洲/中东/非洲
    • 主要趋势和机会
    • 市场规模和预测：按部分分类
      • LAMEA 其他组织扩张剂市场，按应用分类
    • 市场规模和预测：按产品形状分类
    • 最终用户的市场规模和预测
    • 市场规模和预测：按国家/地区分类
      • 巴西
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
      • 沙特阿拉伯
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
      • 南非
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测
      • 拉丁美洲其他地区/中东/非洲
      • 主要市场趋势、增长动力和机遇
      • 市场规模和预测：按部分分类
      • 市场规模和预测：按产品形状分类
      • 最终用户的市场规模和预测

第八章竞争格局

  • 介绍
  • 关键成功策略
  • 10 家主要公司的产品映射
  • 比赛仪表板
  • 竞争热图
  • 定位顶级公司，2021 年

第九章公司简介

  • GC Aesthetics PLC
  • Abbvie Inc
  • Guangzhou Wanhe Plastic Materials Co. Ltd
  • Johnson & Johnson
  • Groupe Sebbin SAS
  • Sientra, Inc.
  • PMT Corporation
  • Establishment Labs
  • Silimed
  • POLYTECH Health & Aesthetics GmbH
Product Code: A13407

The Tissue Expanders Market valued for $671.5 million in 2021 and is estimated to reach $1,180.0 million by 2031, exhibiting a CAGR of 5.8% from 2022 to 2031. Tissue expanders are balloons made of silicon and filler ingredients, molded into a pre-shaped prosthesis, which can be filled with saline through a valve system, which is either incorporated on the expander's surface (early expanders had this structure which is not seen nowadays) or is remote and connected by a flexible silastic filling tube to the expander (nearly all expanders nowadays have a remote valve). The main benefit of the remote valve and filling tube is that it keeps the injection point far from the balloon, eliminating any potential hazards of balloon puncture during expander inflation. Remote positioning enables placing at a location beneath the skin where it can be felt readily.

The growth of tissue expanders market is driven by technological advancement for development of different tissue expanders and rise in the prevalence of breast cancer. In addition, increase in number of various strategies such as product launch and product approval by the market key players is anticipated to drive the growth of market. Breast cancer is the most common type of cancer in women and it necessitates mastectomy to remove malignant cells, resulting in an increase in the use of extremity tissue expanders for breast reconstruction. Thus, rise in number of female patients suffering from breast cancer is anticipated to drive the demand for tissue expanders and fuel the market growth.

Rise in the adoption of minimally invasive procedure for improvement of aesthetic appearance is expected to drive the demand for tissue expanders and boost the market growth. For instance, according to the International Society of Aesthetic Plastic Surgery, in 2020, it was reported that, approximately 10,129,528 cosmetic procedures were performed by plastic surgeons worldwide. Tissue expanders are used for scalp reconstruction, breast reconstruction, oral & maxillofacial reconstruction, and to repair burn scars. Thus, rise in number of burn injuries and oral & maxillofacial deformity lead to upsurge in demand for tissue expanders.

In addition, the Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, & security of human & veterinary drugs, biological products, and medical devices. Rise in product approval for tissue expanders by Food and Drug Administration (FDA) is anticipated to drive the growth of tissue expanders market. For instance, in October 2022, according to Food and Drug Administration, it was reported that, the FDA has cleared 48 tissue expanders and accessories.

In addition, rise in expenditure by governments to develop healthcare infrastructure is anticipated to drive the market growth. For instance, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.0% of the gross domestic product (GDP) in 2020, as compared to 9.9% in 2019. Furthermore, it has been estimated that 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment used at public health centers, such as hospitals and clinics. Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for tissue expanders for reconstructive procedures, thereby boosting the market growth.

On the other hand, high cost of treatment and side effects of the tissue expansion procedures are some factors that are anticipated to restrain the growth of the tissue expanders market.

The tissue expanders market is segmented on the basis of lesion site, product shape, application, end user, and region. By product type, the market is fragmented into lower extremity, upper extremity, and others. The others segment is further divided into trunk, back, and head. By product shape, the market is categorized into rectangular, crescent, round, and others. The others segment is further divided into anatomical, elliptical, and cylindrical. On the basis of application, the market is classified into breast reconstruction, facial reconstruction, and others. The others segment is further divided into congenital disorders, burn scar, and scalp reconstruction. By end user, the market is fragmented into hospitals, cosmetic clinics, and others. The others segment is further bifurcated into ambulatory surgical centers and burn center. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global tissue expanders market include: GC aesthetic PLC, Abbvie Inc, Guangzhou Wanhe Plastic Materials Co. Ltd., Johnson & Johnson, Groupe Sebbin SAS, Sientra, Inc., pmt corporation, POLYTECH Health & Aesthetics Establishment Labs, and Silimed.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the tissue expanders market analysis from 2021 to 2031 to identify the prevailing tissue expanders market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the tissue expanders market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global tissue expanders market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Lesion Site

  • Lower Extremity
  • Upper Extremity
  • Others
    • Application
    • Breast reconstruction
    • Facial reconstruction
    • Others

By Product Shape

  • Rectangular
  • Crescent
  • Round
  • Others

By End User

  • Others
  • Hospitals
  • Cosmetic Clinics

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Abbvie Inc
  • Johnson & Johnson
  • Groupe Sebbin SAS
  • Sientra, Inc.
  • PMT Corporation
  • Establishment Labs
  • Silimed
  • POLYTECH Health & Aesthetics GmbH
  • Guangzhou Wanhe Plastic Materials Co. Ltd
  • GC Aesthetics PLC

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. High bargaining power of suppliers
    • 3.3.2. Moderate bargaining power of buyers
    • 3.3.3. High threat of substitutes
    • 3.3.4. High threat of new entrants
    • 3.3.5. High intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in the number of minimally invasive surgeries.
      • 3.4.1.2. Rise in the prevalence of breast cancer.
      • 3.4.1.3. Increase in the awareness regarding cosmetic surgeries.
    • 3.4.2. Restraints
      • 3.4.2.1. Side effects of reconstructive surgery.
    • 3.4.3. Opportunities
      • 3.4.3.1. Increase in the number of adoptions of key strategies by market players.
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: TISSUE EXPANDERS MARKET, BY LESION SITE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Lower Extremity
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Upper Extremity
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Others
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
    • 4.4.4. Others Tissue Expanders Market by Application
      • 4.4.4.1. Breast reconstruction Market size and forecast, by region
      • 4.4.4.2. Facial reconstruction Market size and forecast, by region
      • 4.4.4.3. Others Market size and forecast, by region

CHAPTER 5: TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Rectangular
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Crescent
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Round
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: TISSUE EXPANDERS MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Cosmetic Clinics
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: TISSUE EXPANDERS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Lesion Site
      • 7.2.2.1. North America Others Tissue Expanders Market by Application
    • 7.2.3. Market size and forecast, by Product Shape
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Lesion Site
      • 7.2.5.1.3. Market size and forecast, by Product Shape
      • 7.2.5.1.4. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Lesion Site
      • 7.2.5.2.3. Market size and forecast, by Product Shape
      • 7.2.5.2.4. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Lesion Site
      • 7.2.5.3.3. Market size and forecast, by Product Shape
      • 7.2.5.3.4. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Lesion Site
      • 7.3.2.1. Europe Others Tissue Expanders Market by Application
    • 7.3.3. Market size and forecast, by Product Shape
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Lesion Site
      • 7.3.5.1.3. Market size and forecast, by Product Shape
      • 7.3.5.1.4. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Lesion Site
      • 7.3.5.2.3. Market size and forecast, by Product Shape
      • 7.3.5.2.4. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Lesion Site
      • 7.3.5.3.3. Market size and forecast, by Product Shape
      • 7.3.5.3.4. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Lesion Site
      • 7.3.5.4.3. Market size and forecast, by Product Shape
      • 7.3.5.4.4. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Lesion Site
      • 7.3.5.5.3. Market size and forecast, by Product Shape
      • 7.3.5.5.4. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Lesion Site
      • 7.3.5.6.3. Market size and forecast, by Product Shape
      • 7.3.5.6.4. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Lesion Site
      • 7.4.2.1. Asia-Pacific Others Tissue Expanders Market by Application
    • 7.4.3. Market size and forecast, by Product Shape
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Lesion Site
      • 7.4.5.1.3. Market size and forecast, by Product Shape
      • 7.4.5.1.4. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Lesion Site
      • 7.4.5.2.3. Market size and forecast, by Product Shape
      • 7.4.5.2.4. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Lesion Site
      • 7.4.5.3.3. Market size and forecast, by Product Shape
      • 7.4.5.3.4. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Lesion Site
      • 7.4.5.4.3. Market size and forecast, by Product Shape
      • 7.4.5.4.4. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Lesion Site
      • 7.4.5.5.3. Market size and forecast, by Product Shape
      • 7.4.5.5.4. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Lesion Site
      • 7.4.5.6.3. Market size and forecast, by Product Shape
      • 7.4.5.6.4. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Lesion Site
      • 7.5.2.1. LAMEA Others Tissue Expanders Market by Application
    • 7.5.3. Market size and forecast, by Product Shape
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Lesion Site
      • 7.5.5.1.3. Market size and forecast, by Product Shape
      • 7.5.5.1.4. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Lesion Site
      • 7.5.5.2.3. Market size and forecast, by Product Shape
      • 7.5.5.2.4. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Lesion Site
      • 7.5.5.3.3. Market size and forecast, by Product Shape
      • 7.5.5.3.4. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Lesion Site
      • 7.5.5.4.3. Market size and forecast, by Product Shape
      • 7.5.5.4.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. GC Aesthetics PLC
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
  • 9.2. Abbvie Inc
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. Guangzhou Wanhe Plastic Materials Co. Ltd
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. Johnson & Johnson
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. Groupe Sebbin SAS
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
  • 9.6. Sientra, Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
  • 9.7. PMT Corporation
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. Establishment Labs
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
    • 9.8.7. Key strategic moves and developments
  • 9.9. Silimed
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. POLYTECH Health & Aesthetics GmbH
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 02. TISSUE EXPANDERS MARKET FOR LOWER EXTREMITY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 03. TISSUE EXPANDERS MARKET FOR UPPER EXTREMITY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 04. TISSUE EXPANDERS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 05. GLOBAL OTHERS TISSUE EXPANDERS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 06. TISSUE EXPANDERS MARKET FOR BREAST RECONSTRUCTION, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 07. TISSUE EXPANDERS MARKET FOR FACIAL RECONSTRUCTION, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 08. TISSUE EXPANDERS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 09. GLOBAL TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. TISSUE EXPANDERS MARKET FOR RECTANGULAR, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. TISSUE EXPANDERS MARKET FOR CRESCENT, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. TISSUE EXPANDERS MARKET FOR ROUND, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. TISSUE EXPANDERS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. GLOBAL TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. TISSUE EXPANDERS MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. TISSUE EXPANDERS MARKET FOR COSMETIC CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. TISSUE EXPANDERS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. TISSUE EXPANDERS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. NORTH AMERICA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. NORTH AMERICA OTHERS TISSUE EXPANDERS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. NORTH AMERICA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. NORTH AMERICA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. NORTH AMERICA TISSUE EXPANDERS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. U.S. TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. U.S. TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. U.S. TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. CANADA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. CANADA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. CANADA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. MEXICO TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. MEXICO TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. MEXICO TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. EUROPE TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. EUROPE OTHERS TISSUE EXPANDERS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. EUROPE TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. EUROPE TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. EUROPE TISSUE EXPANDERS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. GERMANY TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. GERMANY TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. GERMANY TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. FRANCE TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. FRANCE TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. FRANCE TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. UK TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. UK TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. UK TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. ITALY TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. ITALY TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ITALY TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. SPAIN TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. SPAIN TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. SPAIN TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. REST OF EUROPE TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. REST OF EUROPE TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. REST OF EUROPE TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. ASIA-PACIFIC TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. ASIA-PACIFIC OTHERS TISSUE EXPANDERS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. ASIA-PACIFIC TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. ASIA-PACIFIC TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. ASIA-PACIFIC TISSUE EXPANDERS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. JAPAN TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. JAPAN TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. JAPAN TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. CHINA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. CHINA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. CHINA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. INDIA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. INDIA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. INDIA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. AUSTRALIA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. AUSTRALIA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. AUSTRALIA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. SOUTH KOREA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. SOUTH KOREA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. SOUTH KOREA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. REST OF ASIA-PACIFIC TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. REST OF ASIA-PACIFIC TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. REST OF ASIA-PACIFIC TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. LAMEA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. LAMEA OTHERS TISSUE EXPANDERS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. LAMEA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. LAMEA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. LAMEA TISSUE EXPANDERS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. BRAZIL TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. BRAZIL TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. BRAZIL TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. SAUDI ARABIA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 88. SAUDI ARABIA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 89. SAUDI ARABIA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 90. SOUTH AFRICA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 91. SOUTH AFRICA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 92. SOUTH AFRICA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 93. REST OF LAMEA TISSUE EXPANDERS MARKET, BY LESION SITE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 94. REST OF LAMEA TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 95. REST OF LAMEA TISSUE EXPANDERS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 96. GC AESTHETICS PLC: KEY EXECUTIVES
  • TABLE 97. GC AESTHETICS PLC: COMPANY SNAPSHOT
  • TABLE 98. GC AESTHETICS PLC: PRODUCT SEGMENTS
  • TABLE 99. GC AESTHETICS PLC: PRODUCT PORTFOLIO
  • TABLE 100. ABBVIE INC: KEY EXECUTIVES
  • TABLE 101. ABBVIE INC: COMPANY SNAPSHOT
  • TABLE 102. ABBVIE INC: PRODUCT SEGMENTS
  • TABLE 103. ABBVIE INC: PRODUCT PORTFOLIO
  • TABLE 104. GUANGZHOU WANHE PLASTIC MATERIALS CO. LTD: KEY EXECUTIVES
  • TABLE 105. GUANGZHOU WANHE PLASTIC MATERIALS CO. LTD: COMPANY SNAPSHOT
  • TABLE 106. GUANGZHOU WANHE PLASTIC MATERIALS CO. LTD: PRODUCT SEGMENTS
  • TABLE 107. GUANGZHOU WANHE PLASTIC MATERIALS CO. LTD: PRODUCT PORTFOLIO
  • TABLE 108. JOHNSON & JOHNSON: KEY EXECUTIVES
  • TABLE 109. JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • TABLE 110. JOHNSON & JOHNSON: PRODUCT SEGMENTS
  • TABLE 111. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
  • TABLE 112. GROUPE SEBBIN SAS: KEY EXECUTIVES
  • TABLE 113. GROUPE SEBBIN SAS: COMPANY SNAPSHOT
  • TABLE 114. GROUPE SEBBIN SAS: PRODUCT SEGMENTS
  • TABLE 115. GROUPE SEBBIN SAS: PRODUCT PORTFOLIO
  • TABLE 116. SIENTRA, INC.: KEY EXECUTIVES
  • TABLE 117. SIENTRA, INC.: COMPANY SNAPSHOT
  • TABLE 118. SIENTRA, INC.: PRODUCT SEGMENTS
  • TABLE 119. SIENTRA, INC.: PRODUCT PORTFOLIO
  • TABLE 120. PMT CORPORATION: KEY EXECUTIVES
  • TABLE 121. PMT CORPORATION: COMPANY SNAPSHOT
  • TABLE 122. PMT CORPORATION: PRODUCT SEGMENTS
  • TABLE 123. PMT CORPORATION: PRODUCT PORTFOLIO
  • TABLE 124. ESTABLISHMENT LABS: KEY EXECUTIVES
  • TABLE 125. ESTABLISHMENT LABS: COMPANY SNAPSHOT
  • TABLE 126. ESTABLISHMENT LABS: PRODUCT SEGMENTS
  • TABLE 127. ESTABLISHMENT LABS: PRODUCT PORTFOLIO
  • TABLE 128. ESTABLISHMENT LABS: KEY STRATERGIES
  • TABLE 129. SILIMED: KEY EXECUTIVES
  • TABLE 130. SILIMED: COMPANY SNAPSHOT
  • TABLE 131. SILIMED: PRODUCT SEGMENTS
  • TABLE 132. SILIMED: PRODUCT PORTFOLIO
  • TABLE 133. POLYTECH HEALTH & AESTHETICS GMBH: KEY EXECUTIVES
  • TABLE 134. POLYTECH HEALTH & AESTHETICS GMBH: COMPANY SNAPSHOT
  • TABLE 135. POLYTECH HEALTH & AESTHETICS GMBH: PRODUCT SEGMENTS
  • TABLE 136. POLYTECH HEALTH & AESTHETICS GMBH: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. TISSUE EXPANDERS MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF TISSUE EXPANDERS MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN TISSUE EXPANDERS MARKET (2022-2031)
  • FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06. HIGH THREAT OF SUBSTITUTES
  • FIGURE 07. HIGH THREAT OF NEW ENTRANTS
  • FIGURE 08. HIGH INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALTISSUE EXPANDERS MARKET
  • FIGURE 10. TISSUE EXPANDERS MARKET, BY LESION SITE, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR LOWER EXTREMITY, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR UPPER EXTREMITY, BY COUNTRY 2021-2031(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 14. TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE, 2021(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR RECTANGULAR, BY COUNTRY 2021-2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR CRESCENT, BY COUNTRY 2021-2031(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR ROUND, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 19. TISSUE EXPANDERS MARKET, BY END USER, 2021(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR COSMETIC CLINICS, BY COUNTRY 2021-2031(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF TISSUE EXPANDERS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 23. TISSUE EXPANDERS MARKET BY REGION, 2021
  • FIGURE 24. U.S. TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. CANADA TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. MEXICO TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. GERMANY TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. FRANCE TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. UK TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. ITALY TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. SPAIN TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. REST OF EUROPE TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. JAPAN TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. CHINA TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. INDIA TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. AUSTRALIA TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. SOUTH KOREA TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. REST OF ASIA-PACIFIC TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. BRAZIL TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. SAUDI ARABIA TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. SOUTH AFRICA TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. REST OF LAMEA TISSUE EXPANDERS MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47. COMPETITIVE DASHBOARD
  • FIGURE 48. COMPETITIVE HEATMAP: TISSUE EXPANDERS MARKET
  • FIGURE 49. TOP PLAYER POSITIONING, 2021
  • FIGURE 50. ABBVIE INC: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 51. ABBVIE INC: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 52. ABBVIE INC: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 53. JOHNSON & JOHNSON: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 54. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 55. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 56. SIENTRA, INC.: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 57. SIENTRA, INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 58. SIENTRA, INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 59. ESTABLISHMENT LABS: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 60. ESTABLISHMENT LABS: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 61. ESTABLISHMENT LABS: REVENUE SHARE BY REGION, 2021 (%)